1Cohen S, Levi-Montalcini R. Purification and properties of a nerve growth-promoting factor isolated from mouse sarcoma 180 [J]. Cancer Res, 1957, 17(1): 15-20.
2Davies AM, Bandtlow C, Heumann R, et al. Timing and site of nerve growth factor synthesis in developing skin in relation to innervation and expression of the receptor[J]. Nature, 1987, 326(6111): 353-358.
3Micera A, Puxeddu I, Aloe L, et ol. New insights on the involvement of Nerve Growth Factor in allergic inflammation and fibrosis[J]. Cytokine Growth Factor Rev, 2003, 14(5): 369-374.
4Toyoda M, Nakamura M, Makino T, et ol. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis[J]. Br J Dermatol, 2002, 147(1): 71-79.
5Kim KH, Park KC, Chung JH, et ol. The effect of substance P on peripheral blood mononuclear cells in patients with atopic dermatitis[J]. J Dermatol Sci, 2003, 32(2): 115-124.
6Pincelli C, Marconi A. Autocrine nerve growth factor in human keratinocytes[J]. J Dermatol Sci, 2000, 22(2): 71-79.
7Pincelli C. Nerve growth factor and keratinocytes: a role in psoriasis[J]. Eur J Dermatol, 2000, 10(2): 85-90.
8Burbach G J, Kim KH, Zivony AS, et al. The neurosensory tachykinins substance P and neurokinin A directly induce keratinocyte nerve growth factor[J]. J Invest Dermatol, 2001, 117(5):1075-1082.
9Yu HS, Wu CS, Yu CL, et al. Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo [J]. J Invest Dermatol,2003, 120(1): 56-64.
10Falabella R, Barona M1, Echeverri 1C, et ol. Substance P may play a part during depigmentation in vitiligo. A pilot study[J]. J Eur Acad Dermatol Venereol, 2003, 17(3): 355-356.
